Deceptive Conducts before the Patent Office
In an increasingly harmonized global patent landscape, few issues still distinguish the US patent system as much as its strict–and often criticized–duty of candor and its inequitable conduct doctrine. The EPO and most other countries around the world impose less burdensome disclosure duties upon pat...
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Online |
| Język: | angielski |
| Wydane: |
Nomos Verlagsgesellschaft mbH & Co. KG
2021
|
| Hasła przedmiotowe: | |
| Dostęp online: | 38365 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
| _version_ | 1869515358129356800 |
|---|---|
| author | Hoss, Eugenio |
| author_browse | Hoss, Eugenio |
| author_facet | Hoss, Eugenio |
| author_sort | Hoss, Eugenio |
| collection | Directory of Open Access Books |
| description | In an increasingly harmonized global patent landscape, few issues still distinguish the US patent system as much as its strict–and often criticized–duty of candor and its inequitable conduct doctrine. The EPO and most other countries around the world impose less burdensome disclosure duties upon patent applicants. What is there to learn from the experience in the US? Have these tools resulted in any benefit worth considering? Yet regardless of the disclosure duties imposed upon patent applicants, a deceptive conduct before the Patent Office could lead to unwarranted exclusive rights and have a negative impact on competition. Should antitrust law intervene? Is it a case of sham litigation? This work attempts to answer those questions through a comparative analysis, examining the law and case law in the US and in the EU from both a patent and a competition law perspective and seeking a workable theory of harm. |
| format | Online |
| id | doab-20.500.12854ir-44600 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Nomos Verlagsgesellschaft mbH & Co. KG |
| publisherStr | Nomos Verlagsgesellschaft mbH & Co. KG |
| record_format | ojs |
| spelling | doab-20.500.12854ir-446002023-12-20T16:24:20Z Deceptive Conducts before the Patent Office Hoss, Eugenio K1-7720 pharmazeutischer Patient irreführendes Verhalten Wettbewerbsrecht Patentanmeldung Patentamt high court Supreme Court inequitable conduct Competition Law kristalline Form Patentrecht Apotex Walker Process tert-Butylaminsalz duty of candor Fraud before the Patent Office Perindopril Scheincharakter AstraZeneca Patent Office Servier LJ Jacob patent law bic Book Industry Communication::L Law In an increasingly harmonized global patent landscape, few issues still distinguish the US patent system as much as its strict–and often criticized–duty of candor and its inequitable conduct doctrine. The EPO and most other countries around the world impose less burdensome disclosure duties upon patent applicants. What is there to learn from the experience in the US? Have these tools resulted in any benefit worth considering? Yet regardless of the disclosure duties imposed upon patent applicants, a deceptive conduct before the Patent Office could lead to unwarranted exclusive rights and have a negative impact on competition. Should antitrust law intervene? Is it a case of sham litigation? This work attempts to answer those questions through a comparative analysis, examining the law and case law in the US and in the EU from both a patent and a competition law perspective and seeking a workable theory of harm. 2021-02-11T11:02:26Z 2021-02-11T11:02:26Z 2019-10-25 11:43:48 2019 book 38365 9783748902577 https://directory.doabooks.org/handle/20.500.12854/44600 eng Munich Intellectual Property Law Center – MIPLC image/png Attribution-NonCommercial-NoDerivatives 4.0 International https://www.nomos-elibrary.de/10.5771/9783748902577/deceptive-conducts-before-the-patent-office Nomos Verlagsgesellschaft mbH & Co. KG https://doi.org/10.5771/9783748902577 https://doi.org/10.5771/9783748902577 20c8b06d-3b2b-4af2-acda-fbcfdfea5744 7d48738a-6759-43c9-974a-c93e736baeb1 9783748902577 Max Planck Society (MPG) 335 Max Planck Society (MPG) MPG 04a0tr310 open access |
| spellingShingle | K1-7720 pharmazeutischer Patient irreführendes Verhalten Wettbewerbsrecht Patentanmeldung Patentamt high court Supreme Court inequitable conduct Competition Law kristalline Form Patentrecht Apotex Walker Process tert-Butylaminsalz duty of candor Fraud before the Patent Office Perindopril Scheincharakter AstraZeneca Patent Office Servier LJ Jacob patent law bic Book Industry Communication::L Law Hoss, Eugenio Deceptive Conducts before the Patent Office |
| title | Deceptive Conducts before the Patent Office |
| title_full | Deceptive Conducts before the Patent Office |
| title_fullStr | Deceptive Conducts before the Patent Office |
| title_full_unstemmed | Deceptive Conducts before the Patent Office |
| title_short | Deceptive Conducts before the Patent Office |
| title_sort | deceptive conducts before the patent office |
| topic | K1-7720 pharmazeutischer Patient irreführendes Verhalten Wettbewerbsrecht Patentanmeldung Patentamt high court Supreme Court inequitable conduct Competition Law kristalline Form Patentrecht Apotex Walker Process tert-Butylaminsalz duty of candor Fraud before the Patent Office Perindopril Scheincharakter AstraZeneca Patent Office Servier LJ Jacob patent law bic Book Industry Communication::L Law |
| topic_facet | K1-7720 pharmazeutischer Patient irreführendes Verhalten Wettbewerbsrecht Patentanmeldung Patentamt high court Supreme Court inequitable conduct Competition Law kristalline Form Patentrecht Apotex Walker Process tert-Butylaminsalz duty of candor Fraud before the Patent Office Perindopril Scheincharakter AstraZeneca Patent Office Servier LJ Jacob patent law bic Book Industry Communication::L Law |
| url | 38365 |
| work_keys_str_mv | AT hosseugenio deceptiveconductsbeforethepatentoffice |